User profiles for Magnus Ekstrom

Magnus Ekström

- Verified email at regionblekinge.se - Cited by 5489

Magnus Ekström

- Verified email at umu.se - Cited by 870

[HTML][HTML] Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA …

BI Nwaru, M Ekström, P Hasvold… - European …, 2020 - Eur Respiratory Soc
Background Overuse of short-acting β 2 -agonists (SABA) may indicate poor asthma control
and adverse health outcomes. Contemporary population-based data on use, risk factors and …

Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study

MP Ekström, A Bornefalk-Hermansson, AP Abernethy… - Bmj, 2014 - bmj.com
Objective To evaluate the safety of benzodiazepines and opioids in patients with very severe
chronic obstructive pulmonary disease (COPD). Design Population based longitudinal …

Home oxygen therapy for adults with chronic lung disease. An official American Thoracic Society clinical practice guideline

…, B Carlin, MB Drummond, M Ekström… - American journal of …, 2020 - atsjournals.org
Background: Evidence-based guidelines are needed for effective delivery of home oxygen
therapy to appropriate patients with chronic obstructive pulmonary disease (COPD) and …

Towards an expert consensus to delineate a clinical syndrome of chronic breathlessness

…, R Lansing, M Ekström… - European …, 2017 - Eur Respiratory Soc
Breathlessness that persists despite treatment for the underlying conditions is debilitating.
Identifying this discrete entity as a clinical syndrome should raise awareness amongst patients…

[HTML][HTML] The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease

…, S Doe, J Duckers, A d'Urzo, M Ekström… - The Lancet …, 2021 - thelancet.com
Persistent ill health after acute COVID-19—referred to as long COVID, the post-acute COVID-19
syndrome, or the post-COVID-19 condition—has emerged as a major concern. We …

Adaptation of the Charlson comorbidity index for register-based research in Sweden

…, L Byberg, JJ Carrero, AM Ekström, M Ekström… - Clinical …, 2021 - Taylor & Francis
Purpose Comorbidity indices are often used to measure comorbidities in register-based
research. We aimed to adapt the Charlson comorbidity index (CCI) to a Swedish setting. …

Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review

M Ekström, F Nilsson, AA Abernethy… - Annals of the American …, 2015 - atsjournals.org
Rationale: Patients with chronic obstructive pulmonary disease (COPD) commonly suffer from
breathlessness, deconditioning, and reduced health-related quality of life (HRQL) despite …

Effects of cardiovascular drugs on mortality in severe chronic obstructive pulmonary disease: a time-dependent analysis

MP Ekström, AB Hermansson… - American journal of …, 2013 - atsjournals.org
Rationale: Cardiovascular drugs may improve survival in chronic obstructive pulmonary
disease (COPD). However, previous studies did not account for major sources of bias, and drug …

COVID-19: guidance on palliative care from a European Respiratory Society international task force

DJA Janssen, M Ekström, DC Currow… - European respiratory …, 2020 - Eur Respiratory Soc
Background Many people are dying from coronavirus disease 2019 (COVID-19), but consensus
guidance on palliative care in COVID-19 is lacking. This new life-threatening disease …

One evidence base; three stories: do opioids relieve chronic breathlessness?

M Ekström, S Bajwah, JM Bland, DC Currow, J Hussain… - Thorax, 2018 - thorax.bmj.com
The efficacy of low-dose systemic opioids for chronic breathlessness was questioned by the
recent Cochrane review by Barnes et al. We examined the reasons for this conflicting finding …